跳至主要内容
临床试验/NCT06960447
NCT06960447尚未招募不适用

Comparative Efficacy of Nd:YAG and Alexandrite Laser Treatments in Hidradenitis Suppurativa: A Split-Person, Non-Inferiority Study

Geisinger Clinic0 个研究点目标入组 21 人开始时间: 2026年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
21
主要终点
HiSCR50

研究概览

简要总结

The purpose of this study is to evaluate whether Alexandrite laser treatment is non-inferior to Nd:YAG (neodymium-doped yttrium aluminum garnet) laser treatment of hidradenitis suppurativa (HS).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Geisinger male or female patients with a diagnosis of hidradenitis suppurativa (all stages of disease)
  • •12-75 years of age
  • •Not on concurrent systemic therapy (e.g., antibiotics, biologic therapies)
  • •Must have not used systemic therapies within 2 weeks of enrollment in study
  • •Able and willing to provide consent

排除标准

  • •Patients who cannot tolerate laser therapy
  • •Patients who cannot wear protective eyewear
  • •Patients who are pregnant

研究组 & 干预措施

Receiving treatment with both laser types

Experimental

Participants will receive split-body treatment, receiving Nd:YAG laser treatment to an affected anatomical site (axilla, inframammary region, or groin) and Alexandrite laser to the contralateral side. The treatment side will be randomized and maintained through the study.

干预措施: Nd:YAG Laser (Device)

Receiving treatment with both laser types

Experimental

Participants will receive split-body treatment, receiving Nd:YAG laser treatment to an affected anatomical site (axilla, inframammary region, or groin) and Alexandrite laser to the contralateral side. The treatment side will be randomized and maintained through the study.

干预措施: Alexandrite Laser (Device)

结局指标

主要结局

HiSCR50

时间窗: 6 months

Percentage of patients achieving a 50% reduction in their hidradenitis suppurativa clinical response (HiSCR) score.

HiSQOL

时间窗: 6 months

The Hidradenitis Suppurativa Quality Of Life (HiSQOL) scale, a validated HS quality of life index and is comprised of a 17-item HS-specific HRQOL instrument with a 7-day recall period. Score ranges from 0 to 68, with higher scores indicating more severe impact

次要结局

  • Pain VAS score(6 months)
  • Pruritus numeric rating scale(6 months)
  • Days free of disease in last 30 days(6 months)
  • AN Count(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mickey Horissian

Assistant Professor of Dermatology

Geisinger Clinic

相似试验